5α-reductase inhibitors (5-ARIs) are used to treat benign prostatic enlargement, a common condition causing urinary outflow obstruction. They also reduce prostate-specific antigen (PSA) by approximately 50%. Our group has recently published that among US military veterans, 5-ARIs are associated...
Library & Search Results
Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults
Bisphosphonates for Postmenopausal Osteoporosis
Bisphosphonates are the first-line pharmacologic treatment for postmenopausal osteoporosis and the most commonly prescribed medication for this condition.1 Bisphosphonates, classified as antiresorptive agents,...
2019 STFM Conference on Practice and Quality Improvement
December 5-8, 2019
SHERATON GRAND PHOENIX • PHOENIX, AZ
Health care delivery is changing. Attend the STFM Conference on Practice and Quality Improvement, and come home with practical skills, information, and resources to transform your practice to achieve the quadruple aim. Learn...
Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD: A Systematic Review
Objectives. To synthesize existing knowledge about the effectiveness and harms of pharmacologic and nonpharmacologic treatments for exacerbations of chronic obstructive pulmonary disease (ECOPD).
Data sources. Embase®, Epub Ahead of Print, In-Process...
Rivaroxaban Versus Vitamin K Antagonist in Antiphospholipid Syndrome: A Randomized Noninferiority Trial
BACKGROUND:
The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain.
OBJECTIVE:
To determine whether rivaroxaban is noninferior to dose-adjusted vitamin K antagonists (VKAs) for thrombotic APS.
DESIGN:
3-year...
University of Wisconsin - Online Healthcare Administration Master’s Degree
The 13-course University of Wisconsin Master of Science in Healthcare Administration enhances your existing patient care or business management experience with a multidisciplinary curriculum designed to produce healthcare leaders. Its online format is ideal for busy professionals like you, who...
Submit a Suggestion for a New Evidence Review
What health care decisions are you struggling with? Would a review of the scientific evidence help inform this decision? Share your ideas with the Agency for Healthcare Research and Quality's (AHRQ) Evidence-based Practice Center (EPC) Program. AHRQ will use these ideas to determine the focus of...
Primary Prevention of Cardiovascular Disease
Atherosclerotic CVD remains the leading cause of death for people of most racial/ethnic groups. In 2010, the AHA suggested metrics of ideal cardiovascular health in 7 domains (blood pressure, physical activity, cholesterol, diet, weight, smoking, and blood glucose). There have since been...
Subconcussive Football Hits May Leave a Telltale Signature of Brain Damage
College football players in the United States endure over 1000 head hits every season. Although many don’t produce symptoms such as dizziness or blurred vision that often accompany frank concussion, these “clinically silent” hits are associated with the same type of brain damage as concussion,...
2019 PAMA Survey - Near Patient Testing Matters Portal
COLA is a leader in gathering data related to the value of near-patient testing to physicians in their practice as well as data about how PAMA-related cuts are impacting patient access to testing. With discussions in Congress related to H.R. 3584, The Laboratory Access for Beneficiaries Act...